Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 19
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2241)
- Volume 19, 2023 (24)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 19, 2023
The Value of Anticoagulation Management Combining Telemedicine and Self-Testing in Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials
Huang Y, Xie Y, Huang L, Han Z
Therapeutics and Clinical Risk Management 2023, 19:279-290
Published Date: 14 March 2023
Predictive Value of Preoperative Diffusion Tensor Imaging for Evaluating Postoperative Outcomes of Supratentorial Glioma in the Motor Function Area
Duy Hung N, Duy Linh N, Ha Vi N, Van Anh NT, Dinh Hieu N, Dai Ha D, Minh Duc N
Therapeutics and Clinical Risk Management 2023, 19:269-278
Published Date: 14 March 2023
Association of Oxygen Therapy with the Natural Disease Progression of Cystic Fibrosis: A Multi-State Model of the European Cystic Fibrosis Society Patient Registry
Gambazza S, Orenti A, Pizzamiglio G, Zolin A, Colombo C, Laquintana D, Ambrogi F
Therapeutics and Clinical Risk Management 2023, 19:255-267
Published Date: 13 March 2023
Congenital Athymia: Unmet Needs and Practical Guidance
Howley E, Davies EG, Kreins AY
Therapeutics and Clinical Risk Management 2023, 19:239-254
Published Date: 13 March 2023
An Individualized Red Blood Cell Transfusion Strategy Using Pediatric Perioperative-Transfusion-Trigger Score Reduced Perioperative Blood Exposure for Children: A Randomized Controlled Clinical Trial
Luo Z, Li Y, Li X, Liao R
Therapeutics and Clinical Risk Management 2023, 19:229-237
Published Date: 11 March 2023
The Safety of Oral Rehydration Solution Jelly for Water and Electrolyte Intake in Patients with Dysphagia
Nakagawa K, Yoshimi K, Yoshizawa A, Aritaki K, Yamaguchi K, Nakane A, Tohara H
Therapeutics and Clinical Risk Management 2023, 19:219-227
Published Date: 9 March 2023
Shifts in Intestinal Metabolic Profile Among Kidney Transplantation Recipients with Antibody-Mediated Rejection
Wang J, Zhang X, Li M, Li R, Zhao M
Therapeutics and Clinical Risk Management 2023, 19:207-217
Published Date: 3 March 2023
Research on the Influence of the Allogeneic Bone Graft in Postoperative Recovery After MOWHTO: A Retrospective Study
Zhong R, Yu G, Wang Y, Fang C, Lu S, Liu Z, Gao J, Yan C, Zhao Q
Therapeutics and Clinical Risk Management 2023, 19:193-205
Published Date: 24 February 2023
Management of Pelvic Inflammatory Disease in Clinical Practice
Yusuf H, Trent M
Therapeutics and Clinical Risk Management 2023, 19:183-192
Published Date: 15 February 2023
Bone Remodelling of the Proximal Femur After Hip Revision with a Metaphyseal-Fixation Femoral Stem Component
Li Z, Li M, Yao X, Liu B, Liu S, Liu Z, Zhang B, Han Y
Therapeutics and Clinical Risk Management 2023, 19:171-181
Published Date: 14 February 2023
Identifying the Risk Factors for Postoperative Sore Throat After Endotracheal Intubation for Oral and Maxillofacial Surgery
Zheng ZP, Tang SL, Fu SL, Wang Q, Jin LW, Zhang YL, Huang RR
Therapeutics and Clinical Risk Management 2023, 19:163-170
Published Date: 10 February 2023
Adherence to Continuous Positive Airway Pressure Therapy in Pediatric Patients with Obstructive Sleep Apnea: A Meta-Analysis
Sawunyavisuth B, Ngamjarus C, Sawanyawisuth K
Therapeutics and Clinical Risk Management 2023, 19:143-162
Published Date: 3 February 2023
Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy
Colbert GB, Madariaga HM, Gaddy A, Elrggal ME, Lerma EV
Therapeutics and Clinical Risk Management 2023, 19:133-142
Published Date: 2 February 2023
Bardet-Biedl Syndrome: Current Perspectives and Clinical Outlook
Melluso A, Secondulfo F, Capolongo G, Capasso G, Zacchia M
Therapeutics and Clinical Risk Management 2023, 19:115-132
Published Date: 30 January 2023
Treatment Outcomes of the Acute Coronary Syndrome Among Patients Attending St. Paul Hospital
Anagaw YK, Yeheyis MM, Ayenew W, Bizuneh GK
Therapeutics and Clinical Risk Management 2023, 19:105-114
Published Date: 27 January 2023
Radiofrequency versus Ethanol Ablation for Single-Session Treatment of Benign Cystic Thyroid Nodules: A Short-Term Retrospective Study
Nguyen VB, Nguyen Thi X, Nguyen Van Vy H, Pham Nguyen TL, Nguyen Hai T, Dinh Toan N, Le CV
Therapeutics and Clinical Risk Management 2023, 19:97-104
Published Date: 24 January 2023
Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease
Raptis DD, Mantzoros CS, Polyzos SA
Therapeutics and Clinical Risk Management 2023, 19:77-96
Published Date: 22 January 2023
Thoracic Paravertebral Block Decreased Body Temperature in Thoracoscopic Lobectomy Patients: A Randomized Controlled Trial
Yan Y, Geng J, Cui X, Lei G, Wu L, Wang G
Therapeutics and Clinical Risk Management 2023, 19:67-76
Published Date: 20 January 2023
Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA)
Fagiuoli S, Toniutto P, Coppola N, Ancona DD, Andretta M, Bartolini F, Ferrante F, Lupi A, Palcic S, Rizzi FV, Re D, Alvarez Nieto G, Hernandez C, Frigerio F, Perrone V, Degli Esposti L, Mangia A
Therapeutics and Clinical Risk Management 2023, 19:57-65
Published Date: 18 January 2023
Management of Urinary Incontinence Following Radical Prostatectomy: Challenges and Solutions
Castellan P, Ferretti S, Litterio G, Marchioni M, Schips L
Therapeutics and Clinical Risk Management 2023, 19:43-56
Published Date: 15 January 2023
Preseptal and Pretarsal Botulinum Toxin Injection in Hemifacial Spasm and Blepharospasm: A 10-Year Comparative Study
Teekaput C, Teekaput K, Thiankhaw K
Therapeutics and Clinical Risk Management 2023, 19:35-42
Published Date: 13 January 2023
Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder
Shaw C, Gibson W
Therapeutics and Clinical Risk Management 2023, 19:27-33
Published Date: 10 January 2023
Nomograms Based on Non-High-Density Lipoprotein to Predict Outcomes in Patients with Prior Coronary Artery Bypass Grafting with Acute Coronary Syndrome: A Single-Center Retrospective Study
Li C, He K, Yang Y, Li K, Chen M, Wang L, Xu X, Li W
Therapeutics and Clinical Risk Management 2023, 19:15-26
Published Date: 5 January 2023
LncRNA AFAP1-AS1 Induces Gefitinib Resistance of Lung Adenocarcinoma Through the miR-653-5p/AGR2 Axis
Zuo T, Jiang P, Fu J, Zhang Y
Therapeutics and Clinical Risk Management 2023, 19:1-13
Published Date: 5 January 2023